ACTR-54. OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED INTERVENTION WITH SKULL REMODELLING SURGERY TO MAXIMIZE LEVELS OF TTFIELDS INTENSITY FOR HIGHER TREATMENT BENEFIT - THE OPTIMAL TTF STUDY

Anders Rosendal Korshoej; Frederik Lundgaard Hansen; Slávka Lukacova; Søren Ole Stigaard Cortnum; Yasmin Lassen-Ramshad; Trine Lignell Guldberg; Christian Rahbek; Nikola Mikic; Axel Thielscher; Jens Christian Hedemann Sørensen; Gorm von Oettingen

ACTR-54. OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED INTERVENTION WITH SKULL REMODELLING SURGERY TO MAXIMIZE LEVELS OF TTFIELDS INTENSITY FOR HIGHER TREATMENT BENEFIT - THE OPTIMAL TTF STUDY

Anders Rosendal Korshoej, Frederik Lundgaard Hansen, Slávka Lukacova, Søren Ole Stigaard Cortnum, Yasmin Lassen-Ramshad, Trine Lignell Guldberg, Christian Rahbek, Nikola Mikic, Axel Thielscher, Jens Christian Hedemann Sørensen, Gorm von Oettingen

Department of Clinical Medicine - The Department of Neurosurgery

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

Original language	Danish
Journal	Neuro-Oncology
Volume	19
Issue	6
ISSN	1522-8517
Publication status	Published - 2017

Cite this

Korshoej, A. R., Lundgaard Hansen, F., Lukacova, S., Cortnum, S. O. S., Lassen-Ramshad, Y., Guldberg, T. L., Rahbek, C., Mikic, N., Thielscher, A., Sørensen, J. C. H., & Oettingen, G. V. (2017). ACTR-54. OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED INTERVENTION WITH SKULL REMODELLING SURGERY TO MAXIMIZE LEVELS OF TTFIELDS INTENSITY FOR HIGHER TREATMENT BENEFIT - THE OPTIMAL TTF STUDY. Neuro-Oncology, 19(6).

@article{763ec13b8a5745d6aa677d2ad2952c26,

title = "ACTR-54. OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED INTERVENTION WITH SKULL REMODELLING SURGERY TO MAXIMIZE LEVELS OF TTFIELDS INTENSITY FOR HIGHER TREATMENT BENEFIT - THE OPTIMAL TTF STUDY",

author = "Korshoej, {Anders Rosendal} and {Lundgaard Hansen}, Frederik and Sl{\'a}vka Lukacova and Cortnum, {S{\o}ren Ole Stigaard} and Yasmin Lassen-Ramshad and Guldberg, {Trine Lignell} and Christian Rahbek and Nikola Mikic and Axel Thielscher and S{\o}rensen, {Jens Christian Hedemann} and Oettingen, {Gorm von}",

year = "2017",

language = "Dansk",

volume = "19",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "6",

}

Korshoej, AR, Lundgaard Hansen, F, Lukacova, S , Cortnum, SOS, Lassen-Ramshad, Y, Guldberg, TL, Rahbek, C, Mikic, N, Thielscher, A, Sørensen, JCH & Oettingen, GV 2017, 'ACTR-54. OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED INTERVENTION WITH SKULL REMODELLING SURGERY TO MAXIMIZE LEVELS OF TTFIELDS INTENSITY FOR HIGHER TREATMENT BENEFIT - THE OPTIMAL TTF STUDY', Neuro-Oncology, vol. 19, no. 6.

ACTR-54. OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED INTERVENTION WITH SKULL REMODELLING SURGERY TO MAXIMIZE LEVELS OF TTFIELDS INTENSITY FOR HIGHER TREATMENT BENEFIT - THE OPTIMAL TTF STUDY. / Korshoej, Anders Rosendal; Lundgaard Hansen, Frederik; Lukacova, Slávka et al.
In: Neuro-Oncology, Vol. 19, No. 6, 2017.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

TY - JOUR

T1 - ACTR-54. OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED INTERVENTION WITH SKULL REMODELLING SURGERY TO MAXIMIZE LEVELS OF TTFIELDS INTENSITY FOR HIGHER TREATMENT BENEFIT - THE OPTIMAL TTF STUDY

AU - Korshoej, Anders Rosendal

AU - Lundgaard Hansen, Frederik

AU - Lukacova, Slávka

AU - Cortnum, Søren Ole Stigaard

AU - Lassen-Ramshad, Yasmin

AU - Guldberg, Trine Lignell

AU - Rahbek, Christian

AU - Mikic, Nikola

AU - Thielscher, Axel

AU - Sørensen, Jens Christian Hedemann

AU - Oettingen, Gorm von

PY - 2017

Y1 - 2017

M3 - Tidsskriftartikel

SN - 1522-8517

VL - 19

JO - Neuro-Oncology

JF - Neuro-Oncology

IS - 6

ER -